Passed by the Senate February 8, 2022 Yeas 48 Nays 1
President of the Senate Passed by the House February 26, 2022 Yeas 85 Nays 10
Speaker of the House of Representatives | CERTIFICATE I, Sarah Bannister, Secretary of the Senate of the State of Washington, do hereby certify that the attached is SUBSTITUTE SENATE BILL 5546 as passed by the Senate and the House of Representatives on the dates hereon set forth.
Secretary Secretary |
Approved | FILED |
| Secretary of State State of Washington |
SUBSTITUTE SENATE BILL 5546
Passed Legislature - 2022 Regular Session
State of Washington | 67th Legislature | 2022 Regular Session |
BySenate Health & Long Term Care (originally sponsored by Senators Keiser, Van De Wege, Cleveland, Conway, Frockt, Hasegawa, Hunt, Lovick, Nguyen, Pedersen, Randall, Stanford, and C. Wilson)
READ FIRST TIME 01/25/22.
AN ACT Relating to insulin affordability; amending RCW
41.05.017; reenacting and amending RCW
48.43.780; providing an effective date; and providing an expiration date.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:
Sec. 1. RCW
48.43.780 and 2020 c 346 s 5 and 2020 c 245 s 1 are each reenacted and amended to read as follows:
(1) Except as required in subsection (2) of this section, a health plan issued or renewed on or after January 1, ((2021))2023, that provides coverage for prescription insulin drugs for the treatment of diabetes must cap the total amount that an enrollee is required to pay for a covered insulin drug at an amount not to exceed ((one hundred dollars))$35 per ((thirty-day))30-day supply of the drug. Prescription insulin drugs must be covered without being subject to a deductible, and any cost sharing paid by an enrollee must be applied toward the enrollee's deductible obligation.
(2) If the federal internal revenue service removes insulin from the list of preventive care services which can be covered by a qualifying health plan for a health savings account before the deductible is satisfied, for a health plan that provides coverage for prescription insulin drugs for the treatment of diabetes and is offered as a qualifying health plan for a health savings account, the carrier must establish the plan's cost sharing for the coverage of prescription insulin for diabetes at the minimum level necessary to preserve the enrollee's ability to claim tax exempt contributions from his or her health savings account under internal revenue service laws and regulations. The office of the insurance commissioner must provide written notice of the change in internal revenue service guidance to affected parties, the chief clerk of the house of representatives, the secretary of the senate, the office of the code reviser, and others as deemed appropriate by the office.
(3) This section expires January 1, ((2023))2024.
Sec. 2. RCW
41.05.017 and 2021 c 280 s 2 are each amended to read as follows:
Each health plan that provides medical insurance offered under this chapter, including plans created by insuring entities, plans not subject to the provisions of Title
48 RCW, and plans created under RCW
41.05.140, are subject to the provisions of RCW
48.43.500,
70.02.045,
48.43.505 through
48.43.535,
48.43.537,
48.43.545,
48.43.550,
70.02.110,
70.02.900,
48.43.190,
48.43.083,
48.43.0128,
48.43.780, and chapter
48.49 RCW.
NEW SECTION. Sec. 3. Section 1 of this act takes effect January 1, 2023.
--- END ---